Showing results (2071-2080 of 3,004) with videos related to

Sort By:
Pageof 301
The Journal of Pediatrics|October 22, 2010
Differential effects of intraventricular hemorrhage and white matter injury on preterm cerebellar growthEmily W Y Tam, Steven P Miller, Colin Studholme, et al.
Pediatric Neurology|February 26, 2005
Infant botulism, type F, presenting at 54 hours of lifeCorinne A Keet, Christine K Fox, Marta Margeta, et al.
The American Journal of Pathology|June 25, 2004
Expression of integrin-alphaE by mucosal mast cells in the intestinal epithelium and its absence in nematode-infected mice lacking the transforming growth factor-beta1-activating integrin alphavbeta6Jeremy K Brown, Pamela A Knight, Alan D Pemberton, et al.
Neuroimage|October 31, 2015
STEAM - Statistical Template Estimation for Abnormality Mapping: A personalized DTI analysis technique with applications to the screening of preterm infantsBrian G Booth, Steven P Miller, Colin J Brown, et al.
Ultrasound in Medicine & Biology|December 25, 2002
Volume quantification of intracardiac mass lesions by transesophageal three-dimensional echocardiographySujood Ahmed, Navin C Nanda, Andrew P Miller, et al.
International Journal of Environmental Research and Public Health|September 13, 2011
Polycyclic aromatic hydrocarbons in maternal and umbilical cord blood from pregnant Hispanic women living in Brownsville, TexasKen Sexton, Jennifer J Salinas, Thomas J McDonald, et al.
Cancer|December 1, 1990
Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease. A Southwest Oncology Group studyC M Mansfield, C Fabian, S Jones, et al.
Annals of Clinical and Laboratory Science|May 1, 1994
Comparison of the Abbott Cell Dyn 3000 SL and the Coulter STKS hematology analyzersD M Stroop, R C Triplett, G Perrotta, et al.
The Journal of the American Paraplegia Society|July 1, 1994
Baseline body temperatures of patients with myelopathyE J Aguilera, J H Frisbie, H R Dillon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphomaDaruka Mahadevan, Amy Stejskal, Laurence S Cooke, et al.
Pageof 301